Clinical Significance of Serum Biomarkers in Stage IV Non-Small-Cell Lung Cancer Treated with PD-1 Inhibitors: LIPI Score, NLR, dNLR, LMR, and PAB

por Chen, Jia, Wei, Sheng, Zhao, Tianye, Zhang, Xunlei, Wang, Yilang, Zhang, Xiaodong
Publicado 2022

Glycolytic Genes Predict Immune Status and Prognosis Non-Small-Cell Lung Cancer Patients with Radiotherapy and Chemotherapy

por Zhao, Tianye, Shao, Jingjing, Liu, Jia, Wang, Yidan, Chen, Jia, He, Song, Wang, Gaoren
Publicado 2023

Adenoid cystic carcinoma of head and neck: Summary and review of imaging findings

por Wang, Yidan, Guo, Xiaoli, Yu, Ke, Shen, Xiying, Liu, Jia, Zhao, Tianye, Gu, Hongmei
Publicado 2023

Tissue inhibitor of metalloproteinase-1 (TIMP-1) as a prognostic biomarker in gastrointestinal cancer: a meta-analysis

por Qin, Lili, Wang, Yueqi, Yang, Na, Zhang, Yangyu, Zhao, Tianye, Wu, Yanhua, Jiang, Jing
Publicado 2021

Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma

por Guo, Jing, Yang, Qiuxing, Wei, Sheng, Shao, Jingjing, Zhao, Tianye, Guo, Liyuan, Liu, Jia, Chen, Jia, Wang, Gaoren
Publicado 2022

EHD2 inhibits the invasive ability of lung adenocarcinoma and improves the prognosis of patients

por Wei, Sheng, Shao, Jingjing, Wang, Jinming, Zhao, Tianye, Liu, Jia, Shen, Xiying, Wang, Yidan, Chen, Haizhen, Wang, Gaoren
Publicado 2022